Now Reading: Karnataka FDA seizes Rs 4.91 crore spurious drugs near Bengaluru
-
01
Karnataka FDA seizes Rs 4.91 crore spurious drugs near Bengaluru
Karnataka’s Food Safety and Drug Administration seized spurious drugs and materials worth Rs 4.91 crore from an unlicensed repacking and relabelling facility at a farmhouse in Bidadi, near Bengaluru. The August 18 raid uncovered 5,640 vials of Cefiavigent 2.5 Injection valued at Rs 3.38 crore, along with other injectables, expired medicines, packaging equipment and forged labels of multinational companies including Pfizer, the Times of India and The Hindu report.
Health Minister UT Khader said the drugs were sourced from Himachal Pradesh and Telangana, relabelled with MNC brand names, and supplied to Karnataka hospitals and pharmacies. The minister told reporters that some mislabelled medicines may have been used in ICUs, and the government is considering forming a Special Investigation Team to probe what he called an international and interstate racket, according to the Deccan Herald. One worker, Prabhu Dev Gowda, has been arrested. Samples have been sent for lab testing, and batch numbers are being blocked on the FDA portal to prevent further sale.
Indian Opinion Analysis
The coverage of the Bidadi drug bust shows a consistent official framing across outlets, with the Health Minister’s statement dominating the narrative. The Hindustan Times and Deccan Chronicle stick closely to the FDA press release, while The Hindu and Deccan Herald add more detail on the seized drugs and legal provisions. The Times of India and Siasat.com carry the Minister’s claim of an interstate network, though this remains unverified. The seized drugs’ value varies slightly (Rs 4.91 crore vs Rs 5 crore), and only the Times of India reports the Minister’s suggestion that such drugs may have reached ICUs. No outlet critically examines how long this went undetected. The middle ground: a serious unlicensed operation was caught, the interstate supply chain and patient harm are allegations under investigation. Watch for the SIT announcement and lab test results, which will determine whether criminal charges reach the supply network’s top.
Coverage: 9 sources, 9 neutral
Sources (9): thehindu.com (neutral report), deccanherald.com (neutral report), timesofindia.indiatimes.com (neutral report), thehindu.com (2) (neutral report), deccanchronicle.com (neutral report), timesofindia.indiatimes.com (2) (neutral report), hindustantimes.com (neutral report), deccanherald.com (2) (neutral report), siasat.com (neutral report)
This story was synthesised by AI from the 9 sources linked above. Methodology and corrections.
Updated: this story now draws on 9 sources.
